Cargando…
Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report
RATIONALE: Cytotoxic T lymphocyte (CTL) immunotherapy is an autologous cellular immune therapy that has been approved for treating patients with malignant tumors. However, there is still limited information regarding the impact of CTL on metastatic prostate cancer (PC) patients with bone metastatic...
Autores principales: | Shi, Junfeng, Chen, Yi, Chen, Yuetong, Shen, Yunzhu, Zhao, Huanyu, Sun, Hui, Chen, Jinfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023702/ https://www.ncbi.nlm.nih.gov/pubmed/29901632 http://dx.doi.org/10.1097/MD.0000000000011111 |
Ejemplares similares
-
Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)
por: Smith, Pamela A., et al.
Publicado: (1997) -
The same human alloreactive T cell clone can help both B lymphocytes and specific cytotoxic precursors
Publicado: (1984) -
An isolated unusual digit metastasis from esophageal carcinoma: a case report
por: Chen, Yi, et al.
Publicado: (2017) -
T-T cell interactions during in vitro cytotoxic T lymphocyte responses. V. Precursor frequencies and specificity of alloreactive helper T cells
Publicado: (1982) -
Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes
Publicado: (1981)